Literature DB >> 17481652

The creatine kinase energy transport system in the failing mouse heart.

Craig A Lygate1, Alexandra Fischer, Liam Sebag-Montefiore, Julie Wallis, Michiel ten Hove, Stefan Neubauer.   

Abstract

Characteristic alterations of the creatine kinase (CK) system occur in heart failure and may contribute to contractile dysfunction. We examined two mouse models of chronic cardiac stress, transverse aortic constriction (TAC) and coronary artery ligation (CAL), and examined the relationship of CK system changes with hypertrophy and heart failure development. C57Bl/6 mice were subjected to TAC or sham surgery and sacrificed after 2-10 weeks according to echocardiographic criteria of myocardial hypertrophy and function to create four groups representing progressive dysfunction from normal, through compensated hypertrophy, to heart failure. Only mice with congestive heart failure had LV total creatine concentration and total CK activity significantly lower than sham values (11% and 30% lower, respectively). However for all aortic banded mice, a linear relationship was observed between ejection fraction and estimated maximal CK reaction velocity. Mice with heart failure also had corresponding decreases in the activities of the Mito-, MM-, and MB-CK isoenzymes, while the BB isoform remained unchanged. To determine whether these changes were model specific, mice were subjected to CAL or sham operation and followed for 7 weeks. Quantitative changes in total creatine, total CK activity, Mito-CK and MM-CK activities were similar for CAL and TAC mice. We conclude that alterations in the creatine kinase system occur during heart failure in mice qualitatively similar to those occurring in larger animals and humans, suggesting that mice are a suitable model for studying the role of such changes in the pathogenesis of heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481652     DOI: 10.1016/j.yjmcc.2007.03.899

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  33 in total

1.  Manganese-enhanced MRI detection of impaired calcium regulation in a mouse model of cardiac hypertrophy.

Authors:  Martin Andrews; Maryellen L Giger; Brian B Roman
Journal:  NMR Biomed       Date:  2014-12-19       Impact factor: 4.044

2.  High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes.

Authors:  Dunja Aksentijević; Craig A Lygate; Kimmo Makinen; Sevasti Zervou; Liam Sebag-Montefiore; Debra Medway; Hannah Barnes; Jurgen E Schneider; Stefan Neubauer
Journal:  Eur J Heart Fail       Date:  2010-10-12       Impact factor: 15.534

3.  Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI.

Authors:  Steffen Bohl; Craig A Lygate; Hannah Barnes; Debra Medway; Lee-Anne Stork; Jeanette Schulz-Menger; Stefan Neubauer; Jurgen E Schneider
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

4.  Metabolic pathways related to oxidative stress in patients with hemoglobin h disease and iron overload.

Authors:  Shyh-Shin Chiou; Chao-Jung Tsao; Shih-Meng Tsai; Ye-Ru Wu; Yu-Mei Liao; Pei-Chin Lin; Li-Yu Tsai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

5.  Normal cardiac function in mice with supraphysiological cardiac creatine levels.

Authors:  Lucia Santacruz; Alejandro Hernandez; Jeffrey Nienaber; Rajashree Mishra; Miguel Pinilla; James Burchette; Lan Mao; Howard A Rockman; Danny O Jacobs
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-22       Impact factor: 4.733

Review 6.  Cardiac metabolism in hypertrophy and heart failure: implications for therapy.

Authors:  N Siddiqi; S Singh; R Beadle; D Dawson; M Frenneaux
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

7.  Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.

Authors:  Gizem Keceli; Ashish Gupta; Joevin Sourdon; Refaat Gabr; Michael Schär; Swati Dey; Carlo G Tocchetti; Annina Stuber; Jacopo Agrimi; Yi Zhang; Michelle Leppo; Charles Steenbergen; Shenghan Lai; Lisa R Yanek; Brian O'Rourke; Gary Gerstenblith; Paul A Bottomley; Yibin Wang; Nazareno Paolocci; Robert G Weiss
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

8.  Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.

Authors:  Darci Phillips; Michiel Ten Hove; Jurgen E Schneider; Colin O Wu; Liam Sebag-Montefiore; Angel M Aponte; Craig A Lygate; Julie Wallis; Kieran Clarke; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

9.  Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.

Authors:  Craig A Lygate; Dunja Aksentijevic; Dana Dawson; Michiel ten Hove; Darci Phillips; Joseph P de Bono; Debra J Medway; Liam Sebag-Montefiore; Imre Hunyor; Keith M Channon; Kieran Clarke; Sevasti Zervou; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  Circ Res       Date:  2013-01-16       Impact factor: 17.367

10.  Chronic creatine kinase deficiency eventually leads to congestive heart failure, but severity is dependent on genetic background, gender and age.

Authors:  Craig A Lygate; Debra J Medway; Philip J Ostrowski; Dunja Aksentijevic; Liam Sebag-Montefiore; Imre Hunyor; Sevasti Zervou; Jurgen E Schneider; Stefan Neubauer
Journal:  Basic Res Cardiol       Date:  2012-07-04       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.